Zura Bio (ZURA) Total Liabilities (2021 - 2026)
Zura Bio (ZURA) posted quarterly Total Liabilities of $11.7 million for Q1 2026, down 44.32% year-over-year from $21.1 million in Q1 2025, and down 5.36% quarter-over-quarter from $12.4 million in Q4 2025.
Zura Bio (ZURA) Total Liabilities (2021 - 2026) Analysis & Trends
Zura Bio's Total Liabilities history runs 6 years deep, the most recent figure standing at $11.7 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 44.32% year-over-year to $11.7 million; the TTM figure through Mar 2026 stood at $11.7 million (down 44.32% YoY), while the FY2025 annual figure was $12.4 million, down 36.4% from the prior year.
- Total Liabilities for Q1 2026 stood at $11.7 million, down from $12.4 million in the prior quarter.
- The five-year high for Total Liabilities was $25.5 million in Q3 2025, with the low at $6.5 million in Q1 2023.
- The 5-year median for Total Liabilities is $17.4 million (2024), against an average of $15.8 million.
- The sharpest annual moves came in 2023 and 2026: Total Liabilities jumped 196.79% in 2023, then plunged 44.32% in 2026.
- Zura Bio's Total Liabilities stood at $14.8 million in 2022, then surged by 43.69% to $21.3 million in 2023, then declined by 8.35% to $19.5 million in 2024, then plunged by 36.4% to $12.4 million in 2025, then retreated by 5.36% to $11.7 million in 2026.
- Business Quant data shows ZURA's Total Liabilities at $11.7 million in Q1 2026, $12.4 million in Q4 2025, and $25.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Zura Bio | 706.30 Mn | 706.30 Mn | - | 16.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.32 Mn |
| Mar 31, 2026 | 11.75 Mn |
| Dec 31, 2025 | 12.41 Mn |
| Sep 30, 2025 | 25.49 Mn |
| Jun 30, 2025 | 18.70 Mn |
| Mar 31, 2025 | 21.09 Mn |
| Dec 31, 2024 | 19.51 Mn |
| Sep 30, 2024 | 18.24 Mn |
| Jun 30, 2024 | 17.44 Mn |
| Mar 31, 2024 | 16.27 Mn |
| Dec 31, 2023 | 21.29 Mn |
| Sep 30, 2023 | 18.96 Mn |
| Jun 30, 2023 | 22.01 Mn |
| Mar 31, 2023 | 6.53 Mn |
| Dec 31, 2022 | 14.82 Mn |
| Sep 30, 2022 | 7.40 Mn |
| Jun 30, 2022 | 7.42 Mn |
| Mar 31, 2022 | 9.91 Mn |
| Dec 31, 2021 | 10.35 Mn |